Frontotemporal Dementia Drug Discovery Program

Action

Published Date

06/29/2009 - 12:00:00

Contact Information

Adam Liebling, 212-901-8005; aliebling@alzdiscovery.org

Deadline

10/01/2009 - 12:00:00

Department

Eligiblity

Nonprofit academic institutions and for-profit biotechnology firms

More Information

Program Area

Programe Purpose

To support investigative research on Alzheimer's Disease and related disorders, and to accelerate work on a cure